Betahistine, tablets 16 mg 30 pcs

Cerebral Circulatory Disorders, Vertigo, Meniere’s Disease

• treatment and prevention of vestibular vertigo of various origins;
• syndromes including vertigo, headache, tinnitus, progressive hearing loss, nausea and vomiting
• syndromes including vertigo and headache, tinnitus, progressive hearing loss, nausea and vomiting;
• Meniere’s disease or syndrome.

.

Active ingredient

Composition

1 tablet contains:

The active ingredient: betahistine dihydrochloride 16 mg;

Auxiliary substances: MCC; lactose (milk sugar); citric acid monohydrate; colloidal silicon dioxide (aerosil); crosspovidone; talc; magnesium stearate.

How to take, the dosage

Internal, with meals. 1/2-1 tablets 3 times a day.

Emprovement is usually seen at the beginning of therapy. Stable therapeutic effect occurs after two weeks of treatment and may increase during several months of treatment. Treatment is long. The duration of therapy is determined individually.

Interaction

In cases of interaction or incompatibility with other drugs are unknown.

Special Instructions

Betahistine has no sedative effect and does not affect the ability to drive or engage in activities requiring rapid psychomotor reactions.

Contraindications

With caution:

Side effects

Gastrointestinal disorders, allergic reactions of the skin (skin rash, itching, urticaria), Quincke’s edema.

Overdose

Symptoms: nausea, vomiting, convulsions.

Treatment: gastric lavage, administration of activated charcoal, symptomatic therapy.

Similarities